Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / ISHARES BIOTECH
-
Total 13F shares
-
16,460,391
-
Share change
-
-5,046,609
-
Total reported value
-
$5,547,563,096
-
Put/Call ratio
-
169%
-
Price per share
-
$338.33
-
Number of holders
-
426
-
Value change
-
-$1,682,919,480
-
Number of buys
-
174
-
Number of sells
-
204
Institutional Holders of ISHARES TR - ISHARES BIOTECH (IBB) as of Q4 2015
As of 31 Dec 2015,
ISHARES TR - ISHARES BIOTECH (IBB) was held by
426 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,460,391 shares.
The largest 10 holders included
GOLDMAN SACHS GROUP INC, BANK OF AMERICA CORP /DE/, MORGAN STANLEY, BNP PARIBAS ARBITRAGE, SA, CITIGROUP INC, UBS Group AG, JPMORGAN CHASE & CO, WELLS FARGO & COMPANY/MN, SG Americas Securities, LLC, and LPL Financial LLC.
This page lists
426
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.